Traditional Cardiovascular Risk Factors and Their Relation to Future Surgery for Valvular Heart Disease or Ascending Aortic Disease: A Case-Referent Study

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2017 May 7

PMID 28476875

Citations 13

Authors

Johan Ljungberg

Bengt Johansson

Karl Gunnar Engstrom

Elin Albertsson

Paul Holmer

Margareta Norberg

Ingvar A Bergdahl

Stefan Soderberg

Affiliations

Soon will be listed here.

Abstract

Background: Risk factors for developing heart valve and ascending aortic disease are based mainly on retrospective data. To elucidate these factors in a prospective manner, we have performed a nested case-referent study using data from large, population-based surveys.

Methods And Results: A total of 777 patients operated for heart valve disease or disease of the ascending aorta had previously participated in population-based health surveys in Northern Sweden. Median time (interquartile range) from survey to surgery was 10.5 (9.0) years. Primary indications for surgery were aortic stenosis (41%), aortic regurgitation (12%), mitral regurgitation (23%), and dilatation/dissection of the ascending aorta (17%). For each case, referents were allocated, matched for age, sex, and geographical area. In multivariable models, surgery for aortic stenosis was predicted by hypertension, high cholesterol levels, diabetes mellitus, and active smoking. Surgery for aortic regurgitation was associated with a low cholesterol level, whereas a high cholesterol level predicted surgery for mitral regurgitation. Hypertension, blood pressure, and previous smoking predicted surgery for disease of the ascending aorta whereas diabetes mellitus was associated with reduced risk. After exclusion of cases with coronary atherosclerosis, only the inverse associations between cholesterol and aortic regurgitation and between diabetes mellitus and disease of the ascending aorta remained.

Conclusions: This is the first truly prospective study of traditional cardiovascular risk factors and their association with valvular heart disease and disease of the ascending aorta. We confirm the strong association between traditional risk factors and aortic stenosis, but only in patients with concomitant coronary artery disease. In isolated valvular heart disease, the impact of traditional risk factors is varying.

Citing Articles

Aortic valve calcification across stages of dysglycemia in middle-aged individuals from the general population.

Wang A, Ostgren C, Norhammar A, Kylhammar D, Jernberg T, Lind L Cardiovasc Diabetol. 2025; 24(1):105.

PMID: 40045270 PMC: 11884113. DOI: 10.1186/s12933-025-02634-7.

Prevalence and impact of diabetes in patients with valvular heart disease.

Lu Q, Lv J, Ye Y, Li Z, Wang W, Zhang B iScience. 2024; 27(3):109084.

PMID: 38375234 PMC: 10875155. DOI: 10.1016/j.isci.2024.109084.

Prognostic effect of stress hyperglycemia ratio on patients with severe aortic stenosis receiving transcatheter aortic valve replacement: a prospective cohort study.

Hu X, Feng D, Zhang Y, Wang C, Chen Y, Niu G Cardiovasc Diabetol. 2024; 23(1):73.

PMID: 38365751 PMC: 10870928. DOI: 10.1186/s12933-024-02160-y.

Influence of diabetes mellitus on the pathological profile of aortic stenosis: a sex-based approach.

Martin-Nunez E, Goni-Oloriz M, Matilla L, Garaikoetxea M, Mourino-Alvarez L, Navarro A Cardiovasc Diabetol. 2023; 22(1):280.

PMID: 37848892 PMC: 10583330. DOI: 10.1186/s12933-023-02009-w.

Nanocarriers of shRNA-Runx2 directed to collagen IV as a nanotherapeutic system to target calcific aortic valve disease.

Voicu G, Mocanu C, Safciuc F, Anghelache M, Deleanu M, Cecoltan S Mater Today Bio. 2023; 20:100620.

PMID: 37063777 PMC: 10102408. DOI: 10.1016/j.mtbio.2023.100620.

References

Taylor J . ESC/EACTS Guidelines on the management of valvular heart disease. Eur Heart J. 2012; 33(19):2371-2. DOI: 10.1093/eurheartj/ehs273. View

Chan K, Teo K, Dumesnil J, Ni A, Tam J . Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation. 2010; 121(2):306-14. DOI: 10.1161/CIRCULATIONAHA.109.900027. View

Weinehall L, Hallgren C, Westman G, Janlert U, Wall S . Reduction of selection bias in primary prevention of cardiovascular disease through involvement of primary health care. Scand J Prim Health Care. 1998; 16(3):171-6. DOI: 10.1080/028134398750003133. View

Ferrario M, Veronesi G, Chambless L, Tunstall-Pedoe H, Kuulasmaa K, Salomaa V . The contribution of educational class in improving accuracy of cardiovascular risk prediction across European regions: The MORGAM Project Cohort Component. Heart. 2014; 100(15):1179-87. DOI: 10.1136/heartjnl-2013-304664. View

Prokin A, cuzdi A, Zivanovic Z, Sekaric J, Kokai Zekic T, Popovic N . Dyslipidemia as a risk factor for primary intracerebral hemorrhage. Med Glas (Zenica). 2014; 11(1):31-6. View

Davis S, Davenport E, Haynes J, Alvarado R . Regurgitant valvular disease prevalence and progression found on echocardiogram in military aviators. Aviat Space Environ Med. 2014; 85(10):1013-8. DOI: 10.3924/ASEM.3924.2014. View

Vahanian A, Alfieri O, Andreotti F, Antunes M, Baron-Esquivias G, Baumgartner H . Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012; 42(4):S1-44. DOI: 10.1093/ejcts/ezs455. View

Blyme A, Asferg C, Nielsen O, Boman K, Gohlke-Barwolf C, Wachtell K . Increased hsCRP is associated with higher risk of aortic valve replacement in patients with aortic stenosis. Scand Cardiovasc J. 2016; 50(3):138-45. DOI: 10.3109/14017431.2016.1151928. View

Glader C, Birgander L, Soderberg S, Ildgruben H, Saikku P, Waldenstrom A . Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis. Eur Heart J. 2003; 24(2):198-208. DOI: 10.1016/s0195-668x(02)00385-8. View

10.

Norberg M, Wall S, Boman K, Weinehall L . The Västerbotten Intervention Programme: background, design and implications. Glob Health Action. 2010; 3. PMC: 2844807. DOI: 10.3402/gha.v3i0.4643. View

11.

Lin T, Su H, Voon W, Lai H, Yen H, Lai W . Association between hypertension and primary mitral chordae tendinae rupture. Am J Hypertens. 2006; 19(1):75-9. DOI: 10.1016/j.amjhyper.2005.06.020. View

12.

Rossebo A, Pedersen T, Boman K, Brudi P, Chambers J, Egstrup K . Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008; 359(13):1343-56. DOI: 10.1056/NEJMoa0804602. View

13.

Prakash S, Pedroza C, Khalil Y, Milewicz D . Diabetes and reduced risk for thoracic aortic aneurysms and dissections: a nationwide case-control study. J Am Heart Assoc. 2012; 1(2). PMC: 3487378. DOI: 10.1161/JAHA.111.000323. View

14.

Cowell S, Newby D, Prescott R, Bloomfield P, Reid J, Northridge D . A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005; 352(23):2389-97. DOI: 10.1056/NEJMoa043876. View

15.

Teichholz L, KREULEN T, Herman M, Gorlin R . Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol. 1976; 37(1):7-11. DOI: 10.1016/0002-9149(76)90491-4. View

16.

Ferreira-Gonzalez I, Pinar-Sopena J, Ribera A, Marsal J, Cascant P, Gonzalez-Alujas T . Prevalence of calcific aortic valve disease in the elderly and associated risk factors: a population-based study in a Mediterranean area. Eur J Prev Cardiol. 2012; 20(6):1022-30. DOI: 10.1177/2047487312451238. View

17.

Badheka A, Singh V, Patel N, Arora S, Patel N, Thakkar B . Trends of Hospitalizations in the United States from 2000 to 2012 of Patients >60 Years With Aortic Valve Disease. Am J Cardiol. 2015; 116(1):132-41. DOI: 10.1016/j.amjcard.2015.03.053. View

18.

Stewart B, Siscovick D, Lind B, Gardin J, Gottdiener J, Smith V . Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997; 29(3):630-4. DOI: 10.1016/s0735-1097(96)00563-3. View

19.

Wang C, Jiang L, Feng S, Shi Y, Shen H, Shi X . Risk factor analysis of calcification in aortic and mitral valves in maintenance peritoneal dialysis patients. Kidney Blood Press Res. 2013; 37(4-5):488-95. DOI: 10.1159/000355729. View

20.

Harris T, Feldman J, Kleinman J, Ettinger Jr W, Makuc D, Schatzkin A . The low cholesterol-mortality association in a national cohort. J Clin Epidemiol. 1992; 45(6):595-601. DOI: 10.1016/0895-4356(92)90131-6. View